Spyre Therapeutics, Inc. (SYRE)

106.65 +0.16 (+0.15%) USD  |  NASDAQ  |  Aug 24, 16:00
107.01 +0.36 (+0.34%) Pre-Market: 08:12
More

Spyre Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
December 31, 2022 --
Date Value
December 31, 2021 --
December 31, 2020 --
December 31, 2019 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
AbbVie, Inc. Upgrade
vTv Therapeutics, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Praxis Precision Medicines, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade